Nicole Lemerond's most recent trade in Medicinova Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Medicinova Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Geovax Labs Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 10,000 | 10,000 | - | - | Stock Option | |
| Medicinova Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 24,500 | 24,500 | - | - | Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Lemerond Nicole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 550 | 975 | - | - | Employee Stock Option (Right to Buy) | |
| Geovax Labs Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 8,050 | 8,050 | - | - | Stock Option | |
| Medicinova Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Lemerond Nicole | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 7,100 | 8,500 | - | - | Employee Stock Option (Right to Buy) | |
| Medicinova Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 18,333 | 18,333 | - | - | Stock Option (Right to Buy) | |
| Geovax Labs Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 50,000 | 50,000 | - | - | Stock Option | |
| InMed Pharmaceuticals Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 840 | 1,400 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Nicole Lemerond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 14,000 | 14,000 | - | - | Employee Stock Option (Right to Buy) |